Ikris Pharma
About Us Named Patient Program
Cities We Serve Contact Us

Diabetes

Diabetes Medicines in India: Imported Tablets and Weekly Injections for Type 2 Diabetes

Written by Nitin Goswami Medically reviewed by Dr. Chirag C Shah Last updated
QUICK ANSWERDiabetes means the blood sugar stays too high, either because the pancreas makes too little insulin or because the body no longer responds to it properly. Type 2 diabetes is by far the most common form in Indian adults, and the national ICMR-INDIAB survey found it in 11.4% of adults, with another 15.3% in the prediabetes range [1]. Metformin and many other tablets are already prescribed widely in India, yet a number of newer molecules approved in China or the US over the last few years are not sold here. Named Patient Program (NPP) arranges 13 of them, including once-weekly injections, a DPP-4 tablet taken once every two weeks, a three-in-one tablet and a capsule for diabetic nerve pain, bringing in each one for one named patient after a diabetologist or endocrinologist has written the prescription.
11.4%
of Indians aged 20 years or more had diabetes, and 15.3% had prediabetes, in a survey of 113,043 people across 31 states and union territories
Source: ICMR-INDIAB-17, Lancet Diabetes Endocrinol 2023 [1]
7.7%
of Indians with known diabetes met all three ABC goals together: HbA1c under 7%, blood pressure under 140/90 and LDL cholesterol under 100 mg/dL
Source: ICMR-INDIAB-13, 5,297 adults [2]
12.5%
of people aged 40 or older with diabetes had diabetic retinopathy on screening, and 4.0% had the sight-threatening stage
Source: SMART India study, 42,146 people screened [3]
39.3%
of 336 adults with type 2 diabetes in rural South India showed peripheral nerve damage on foot testing; 78.6% had an HbA1c above 7
Source: Indian J Community Med 2019 [4]

The main forms of diabetes, and which ones this page covers

Doctors sort diabetes by its cause, because the cause decides the treatment. Every medicine listed here carries an approval for type 2 diabetes in adults or, in one case, for nerve pain that diabetes has caused.

FormWhat is going onHow it is usually treatedOn this page?
Type 2 diabetesThe body resists its own insulin and, over the years, the pancreas cannot keep upDiet, activity and weight control first, then tablets and injections added step by step; some people later need insulinYes, all the sugar-lowering medicines below
Type 1 diabetesThe pancreas makes little or no insulinInsulin every day, as the WHO notes [5]No; none of these medicines is approved for type 1
PrediabetesSugar is above normal but below the diabetes cut-offLifestyle change and regular testingNo
Diabetic nerve painLong-standing high sugar damages the nerves of the feet and legsPain-relief medicines alongside tighter sugar control and foot careYes, one capsule approved in China

Gestational diabetes, which appears in pregnancy, is managed by the obstetric and diabetes team and is not covered here.

What large Indian studies show

  • More common than earlier estimates. Between 2008 and 2020, ICMR-INDIAB took blood samples from adults in villages and towns of every state and union territory surveyed, 31 in all along with Delhi. Diabetes was more frequent in towns and cities than in villages, and in a number of the poorer states (those lower on the human development index) prediabetes was more common than diabetes itself, a sign that numbers there are still climbing [1].
  • Few people reach their targets. Among 5,789 adults who already knew they had diabetes, only 36.3% had an HbA1c under 7%, 48.8% had their blood pressure in range and 41.5% had LDL cholesterol in range. Just 16.7% checked their own sugar at home, and even among insulin users the figure was 36.9% [2].
  • Control improves slowly even with treatment. The LANDMARC study followed 6,234 people with type 2 diabetes in cities and smaller towns for three years. Their average HbA1c at the start was 8.1%. The share with an HbA1c under 7% rose from 25.1% at the start to 36.6% after three years, and insulin use went up from 25.5% to 36.7% over the same period [6, 7].
  • Nerve damage leads the complications. In LANDMARC, neuropathy made up 82.0% of the small-vessel complications reported over three years [6]. A rural South Indian study found that 61% of its patients had a burning feeling in the feet and 36.9% had numbness [4].
  • Eye damage often goes unnoticed. In SMART India, 7,910 of 42,146 people aged 40 and over (18.8%) turned out to have diabetes, and 1,783 of the 6,133 with readable retinal photos did not know it beforehand. The authors estimate that about 3 million Indians aged 40 or more have sight-threatening diabetic retinopathy [3].

How the imported medicines lower blood sugar

LANDMARC showed that metformin (a biguanide), sulfonylureas and DPP-4 inhibitors are the tablets Indian doctors already use most; DPP-4 use rose from 48.9% to 61.2% of patients in two years [6, 7]. The medicines on this page belong to the same broad families or to newer ones, but each is a molecule or a combination that is not on the Indian market. Your doctor chooses by HbA1c, weight, kidney function, heart risk and how many tablets you can manage.

GroupWhat it does in the bodyMedicines here
Weekly incretin injectionsCopy gut hormones released after a meal: more insulin when sugar is high, slower stomach emptying, less appetiteMounjaro (GIP + GLP-1), Mazdutide (GLP-1 + glucagon), Ecnoglutide and Visepegenatide (GLP-1)
DPP-4 inhibitor tabletsStop an enzyme from breaking down those same gut hormones, so the body's own supply lasts longerFotagliptin, Prusogliptin, Retagliptin, Cetagliptin, and Cofrogliptin (one tablet every two weeks)
SGLT2 inhibitor tabletMake the kidneys pass surplus glucose out in the urineGanagliflozin
Fixed-dose combinationsTwo or three of the above actions with metformin in a single tabletRetagliptin + metformin; henagliflozin + retagliptin + metformin
Nerve pain capsuleCalms overactive pain nerves through the alpha-2-delta part of calcium channelsCrisugabalin

Two points stand out for patients. Visepegenatide is started at its full weekly dose with no build-up period, and Mazdutide was the first medicine approved anywhere to act on both the GLP-1 and glucagon receptors.

Imported diabetes medicines by type

All 13 medicines below are prescription-only. Tap a type to filter. Each card opens the full medicine page with dosage, storage and safety details.

Mounjaro (tirzepatide)
Mounjaro
tirzepatide · Pre-filled pen
With diet and exercise to improve sugar control in type 2 diabetes in adults and children aged 10 and over; also lowers the risk of major heart events in high-risk adults with type 2 diabetes
Weekly injection US FDA
Mazdutide (mazdutide)
Mazdutide
mazdutide · Pre-filled pen
Adults with type 2 diabetes, alone or added to metformin, a sulfonylurea or an SGLT2 inhibitor (approved in China September 2025); separately approved for weight management
Weekly injection China NMPA
Ecnoglutide (ecnoglutide)
Ecnoglutide
ecnoglutide · Pre-filled pen
Lowers blood sugar in adults living with type 2 diabetes (China, January 2026); a weight-management approval followed in March 2026
Weekly injection China NMPA
Visepegenatide (visepegenatide)
Visepegenatide
visepegenatide · Pre-filled pen
Adults with type 2 diabetes, alone or with metformin, at one fixed weekly dose from the start (China, November 2025)
Weekly injection China NMPA
Fotagliptin (fotagliptin benzoate)
Fotagliptin
fotagliptin benzoate · Tablet
Once-daily tablet for adults with type 2 diabetes, alone or with metformin (China, June 2024)
DPP-4 tablet China NMPA
Prusogliptin (prusogliptin)
Prusogliptin
prusogliptin · Tablet
Once-daily tablet for adults with type 2 diabetes, alone or added to metformin (China, January 2025)
DPP-4 tablet China NMPA
Retagliptin (retagliptin phosphate)
Retagliptin
retagliptin phosphate · Tablet
Adults with type 2 diabetes, alone or with metformin; the first DPP-4 inhibitor discovered in China (approved June 2023)
DPP-4 tablet China NMPA
Cetagliptin (cetagliptin phosphate)
Cetagliptin
cetagliptin phosphate · Tablet
Once-daily tablet for adults with type 2 diabetes, alone or with metformin (China, December 2024)
DPP-4 tablet China NMPA
Cofrogliptin (cofrogliptin)
Cofrogliptin
cofrogliptin · Tablet
One tablet every two weeks for adults with type 2 diabetes, alone or with metformin (China, June 2024)
DPP-4 tablet China NMPA
Ganagliflozin (ganagliflozin (janagliflozin))
Ganagliflozin
ganagliflozin (janagliflozin) · Tablet
Once-daily SGLT2 tablet for adults with type 2 diabetes, alone or with metformin (China, January 2024)
SGLT2 tablet China NMPA
Retagliptin And Metformin (retagliptin + metformin)
Retagliptin And Metformin
retagliptin + metformin · Tablet
Two-in-one tablet for type 2 diabetes in adults whose doctor wants both retagliptin and metformin (China, May 2025)
Combination tabletDPP-4 tablet China NMPA
Henagliflozin, Retagliptin And Metformin (henagliflozin + retagliptin + metformin)
Henagliflozin, Retagliptin And Metformin
henagliflozin + retagliptin + metformin · Extended-release tablet
Three-in-one tablet for adults whose type 2 diabetes is not controlled on metformin (China, October 2025)
Combination tabletSGLT2 tabletDPP-4 tablet China NMPA
Crisugabalin (crisugabalin besilate)
Crisugabalin
crisugabalin besilate · Capsule
Painful diabetic peripheral neuropathy in adults; also post-shingles nerve pain (China, May 2024)
Diabetic nerve pain China NMPA

Compare all 13 diabetes medicines

MedicineGeneric nameDiabetes typeFormApproved by
MounjarotirzepatideWeekly injectionPre-filled penUS FDA
MazdutidemazdutideWeekly injectionPre-filled penChina NMPA
EcnoglutideecnoglutideWeekly injectionPre-filled penChina NMPA
VisepegenatidevisepegenatideWeekly injectionPre-filled penChina NMPA
Fotagliptinfotagliptin benzoateDPP-4 tabletTabletChina NMPA
PrusogliptinprusogliptinDPP-4 tabletTabletChina NMPA
Retagliptinretagliptin phosphateDPP-4 tabletTabletChina NMPA
Cetagliptincetagliptin phosphateDPP-4 tabletTabletChina NMPA
CofrogliptincofrogliptinDPP-4 tabletTabletChina NMPA
Ganagliflozinganagliflozin (janagliflozin)SGLT2 tabletTabletChina NMPA
Retagliptin And Metforminretagliptin + metforminCombination tablet, DPP-4 tabletTabletChina NMPA
Henagliflozin, Retagliptin And Metforminhenagliflozin + retagliptin + metforminCombination tablet, SGLT2 tablet, DPP-4 tabletExtended-release tabletChina NMPA
Crisugabalincrisugabalin besilateDiabetic nerve painCapsuleChina NMPA

Reports and checks your doctor will look at first

Report or checkWhy it mattersMost relevant to
HbA1c with fasting and after-meal sugarShows how far above target you are and whether one more medicine or a stronger change is neededAll sugar-lowering medicines here
Kidney function (creatinine and eGFR)Our drug pages note that Ganagliflozin needs a kidney check before the first dose and at intervals, and that metformin is not used once eGFR falls below 30Ganagliflozin, both combination tablets
Personal and family thyroid historyThe Mounjaro label has a boxed warning on thyroid C-cell tumours seen in rats; it is not given to anyone who has had medullary thyroid cancer, has a close relative who had it, or has MEN 2Mounjaro
Past pancreatitisPancreatitis has been reported with GLP-1 based injections; the Mounjaro label says to stop if it is suspectedWeekly injections
Retina checkThe Mounjaro label lists diabetic retinopathy complications in people who already have retinopathy, and SMART India shows how often it is missed [3]Weekly injections, and everyone with diabetes
Foot examination with a 10-g monofilamentA quick bedside test for loss of feeling, used in the rural South Indian study [4]Crisugabalin, and everyone with diabetes
List of all current medicinesLow sugar is more likely when a new medicine is added to insulin or a sulfonylurea, so those doses may need to come downAll medicines here

Getting the import permit, keeping pens cold, and planning the cost

Diabetes medicines are taken for years, so it helps to sort out the paperwork once. CDSCO grants the import permit to the patient: the application on Form 12A goes in under the patient's name, our pharmacist puts the file together, and the permit comes back as Form 12B. Our Form 12A and 12B page lists what is needed.

Tablets and capsules travel at ordinary room conditions as their packs allow. Injection pens are different: the US label says Mounjaro pens are stored cold, between 2 °C and 8 °C, and must never be frozen, and our Mazdutide page gives the same range. Pens like these are sent with a temperature logger under our hospital delivery process, so the hospital pharmacy can see the cold chain held all the way.

Because treatment is long term, ask about support schemes before you start. Company programmes, government schemes and charities are covered on our patient support page.

How to get these diabetes medicines in India

1

Prescription
Your doctor prescribes the medicine.

2

Share documents
Send the prescription and latest reports through Online Order.

3

Import paperwork
Our team checks the source and the import permissions.

4

Delivery
Delivered with the right storage, including cold chain.

Read How to Order and Indian import regulations. We also serve patients in Delhi NCR, Bangalore, Chennai, Mumbai, Kolkata, Hyderabad and Pune.

Has your doctor prescribed one of these medicines?

Share the prescription and we will guide you on availability and next steps.

Online Order

Read more about diabetes

References

  1. Anjana RM et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474-489. https://pubmed.ncbi.nlm.nih.gov/37301218/
  2. Anjana RM et al. Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13). Lancet Diabetes Endocrinol. 2022;10(6):430-441. https://pubmed.ncbi.nlm.nih.gov/35461575/
  3. Raman R et al. Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban-rural locations, and socioeconomic indices: results from the SMART India study. Lancet Glob Health. 2022;10(12):e1764-e1773. https://pubmed.ncbi.nlm.nih.gov/36327997/
  4. Darivemula S et al. Prevalence and its associated determinants of diabetic peripheral neuropathy in individuals having type-2 diabetes mellitus in rural South India. Indian J Community Med. 2019;44(2):88-91. https://pubmed.ncbi.nlm.nih.gov/31333282/
  5. World Health Organization. Diabetes – fact sheet. https://www.who.int/news-room/fact-sheets/detail/diabetes
  6. Das AK et al. The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial). Endocrinol Diabetes Metab. 2023;6(5):e422. https://pubmed.ncbi.nlm.nih.gov/37392036/
  7. Das AK et al. Two-year trends from the LANDMARC study in patients with type 2 diabetes mellitus. Endocrinol Diabetes Metab. 2023;6(2):e404. https://pubmed.ncbi.nlm.nih.gov/36722454/
  8. US FDA prescribing information for Mounjaro (DailyMed). https://dailymed.nlm.nih.gov/dailymed/

This page gives general information only and does not replace medical advice. All medicines listed are prescription-only and must be used under a qualified doctor.

Diabetes Medicines:
Questions Patients Ask

Short answers to what patients and families ask us most.

More FAQs

Meet the NPP Assistant: ask us anything about NPP